Read More

Volition Issued Business Review 2022

VolitionRx Limited (NYSE AMERICAN: VNRX) has issued a Business Review of 2022, outlining its key highlights as the organization transitions from a company solely focused on research and development to one with commercial operations. Volition's major achievements in 2022 include:

VNRX